Medicine and Dentistry
Classical Hodgkin Lymphoma
74%
Human Leukocyte Antigen
53%
Hodgkin's Lymphoma
53%
Epstein-Barr Virus
40%
Epstein Barr Virus
35%
Immune Checkpoint Inhibitor
35%
B-Cell Lymphoma
35%
Antigen Expression
23%
Allele
21%
Tumor Cell
20%
Antigen Presentation
20%
Promyelocytic Leukemia Protein
17%
HLA-A
17%
Non-Hodgkin Lymphoma Cell Line
17%
Protein Binding
17%
Synapsin I
17%
Lymphoblastoid Cell Line
17%
Proteomics
17%
Cell Line
11%
Diffuse Large B-Cell Lymphoma
10%
Neoplasm
9%
Cell Surface
8%
B Cell
7%
B-Cell Non-Hodgkin Lymphoma Cell Line
5%
Tandem Mass Spectrometry
5%
Liquid Chromatography-Mass Spectrometry
5%
Gel Electrophoresis
5%
Cyclosporine
5%
Effect Size
5%
Cell Motility
5%
Gene Expression
5%
Non-Hodgkin Lymphoma
5%
Cell Growth
5%
Follicular Lymphoma
5%
Cancer
5%
Cell Metabolism
5%
Comorbidity
5%
Genetic Variability
5%
Immunology and Microbiology
Epstein Barr Virus
100%
Human Leukocyte Antigen
89%
Allele
68%
Antigen Expression
37%
Antigen Presentation
35%
B Cell
25%
Tumor Cell
23%
Single Nucleotide Polymorphism
23%
Promyelocytic Leukemia Protein
17%
Aminopeptidase
17%
Transcription Factor GATA 3
17%
Endoplasmic reticulum
17%
Protein Binding
17%
B Cell Lymphoma Cell
13%
Expression Quantitative Trait Loci
11%
Genetic Variability
10%
Lymphoma Cell
8%
Cell Growth
7%
Cell Surface
6%
Haplotype
5%
T Cell
5%
Keyphrases
Human Leukocyte Antigen
35%
Lymphoma Patients
24%
Immune Checkpoint Inhibitor Therapy
17%
HLA Class I Expression
17%
Promyelocytic Leukemia Protein
17%
Nuclear Bodies
17%
AT-rich Region
17%
Classical Hodgkin Lymphoma
17%
Endoplasmic Reticulum Aminopeptidase
17%
Hodgkin Lymphoma
17%
MiR-150
17%
Antigen Expression
17%
New Human Leukocyte Antigen Allele
17%
Diffuse Large B-cell Lymphoma (DLBCL)
17%
ZDHHC11
17%
Classic Hodgkin Lymphoma
17%
Burkitt Lymphoma
7%
Diffuse Large B-cell Lymphoma Cells
7%
Tumor Cells
7%
Epstein-Barr Virus
7%
Overexpression
5%
Network Components
5%
Expression Level
5%
